Search

everythinglearnresearchcommunity

for

Search:↓

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Control symptoms and use safe treatments for skin conditions like lichen planopilaris and chronic cutaneous lupus erythematosus.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Topical latanoprost and bimatoprost ophthalmic solutions don't help eyelash growth in patients with alopecia areata.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

The document concludes that molluscum contagiosum is a common, benign skin infection in children, often healing without scarring.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Dermoscopy improves diagnosis and treatment monitoring for children's skin infections, inflammations, and hair disorders.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Zinc supplements may be needed to treat hair loss in hypothyroidism.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.